Nabriva appoints new chief medical officer
This article was originally published in Scrip
Executive Summary
Nabriva Therapeutics, an Austrian biotechnology company focused on developing antibiotics for serious infections caused by resistant pathogens, has appointed Dr William Prince chief medical officer. He joins from Surface Logix, where he was chief development officer.